Company Filing History:
Years Active: 2011-2013
Title: Chang-Mau Sheng: Innovator in Cancer Treatment
Introduction
Chang-Mau Sheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, his work focuses on the development of radioactive materials that can effectively inhibit cancer.
Latest Patents
One of his latest patents is titled "Radioactive material containing chitosan for inhibiting cancer and preparation method thereof." This invention reveals a radioactive material formed by using a SOCTA chelating agent to connect chitosan with radionuclides such as Re and Tc-99m. The preparation method involves creating a SOCTA-Chitosan compound and subsequently forming an M(radionuclide)-SOCTA-Chitosan compound. The biocompatibility of chitosan allows the radioactive material to be injected into cancerous areas, providing effective treatment by remaining in the target area for an extended period.
Another significant patent is "Radioactive mixture and manufacturing method thereof." This invention discloses a radioactive mixture formed through a chelating reaction of MN series compounds with TcO or ReO, which is then dissolved in Lipiodol. This mixture is designed to treat liver cancers, breast cancers, and other solid tumors while minimizing injuries caused by surgical operations. The innovative use of Re-188 MN or Re-188 MN/Lipiodol can also be combined with anticancer drugs and other therapeutic modalities.
Career Highlights
Chang-Mau Sheng is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he continues to advance research in nuclear energy applications for medical purposes. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
He collaborates with I-Chung Tang, contributing to the development of innovative solutions in the field of nuclear medicine.
Conclusion
Chang-Mau Sheng's contributions to cancer treatment through his innovative patents highlight the importance of research and development in medical technology. His work exemplifies the potential of combining nuclear science with therapeutic applications to improve patient outcomes.